The AAN, the AES, and the Epilepsy Foundation issued a position statement on seizures, driving, and medical reporting.

AES visited Capitol Hill on Tuesday, Feb. 11 to advocate for the creation of a National Plan for Epilepsy.

Howard P. Goodkin, MD, PhD, FAES, begins his term as president of the American Epilepsy Society (AES) at the conclusion of the Society’s 2024 Annual Meeting, held in Los Angeles, Dec. 6-10, 2024. A medical and scientific society of 5,300 members, AES is dedicated to advancing research and education for preventing, treating and curing epilepsy.

Jack M. Parent, MD, was elected first vice president of the American Epilepsy Society (AES) at the conclusion of the Society’s 2024 Annual Meeting in Los Angeles.

David Labiner, MD, FRSM, FANA, FAES, was elected second vice president of the American Epilepsy Society (AES), at the conclusion of the Society’s 2024 Annual Meeting in Los Angeles.

Kelly Knupp, MD, FAES, was elected treasurer-elect of the American Epilepsy Society (AES) at the conclusion of the Society's annual meeting in Los Angeles.

David G. Vossler, MD, FAAN, FANCS, FAES, has been elected to the American Epilepsy Society (AES) board of directors beginning at the conclusion of the Society's 2024 Annual Meeting in Los Angeles, Dec. 6-10, 2024. A medical and scientific society of more than 5,200 members, the AES is dedicated to advancing research and education for preventing, treating and curing epilepsy.

Barry E. Gidal, PharmD, FAES has been elected to the American Epilepsy Society (AES) board of directors beginning at the conclusion of the Society's 2024 Annual Meeting in Los Angeles, Dec. 6-10, 2024. A medical and scientific society of more than 5,200 members, the AES is dedicated to advancing research and education for preventing, treating and curing epilepsy.

Annapurna Poduri, MD, MPH, FAES, was elected Nominating Committee member at-large for the American Epilepsy Society (AES) at the conclusion of the Society's annual meeting in Los Angeles.

Artificial intelligence (AI) analysis of home videos could accelerate the diagnosis of infantile spasms, a severe form of epilepsy in babies, suggests a study presented at the American Epilepsy Society Annual Meeting.

AES2024 first-of-its-kind study presented on Angiotensin receptor blocker (ARB) drugs.

The vast majority of people in genetic epilepsy studies are of white, European ancestry, skewing the genetic evidence used to guide diagnosis, management and understanding of epilepsy. This likely leads to missed epilepsy risk factors and less-equitable care for those of non-European descent, suggests a first-of-its-kind study of more than 3 million people presented at the American Epilepsy Society Annual Meeting.

A non-invasive technique called low-intensity focused ultrasound (LOFU) holds promise for treating and preventing seizures in the most common form of epilepsy, suggests early research presented at the American Epilepsy Society Annual Meeting.

Many people of childbearing potential may not realize that their antiseizure medications (ASM) can raise the risk of birth defects or make their birth control less effective, suggests a study presented at the American Epilepsy Society Annual Meeting. Additionally, some birth control methods can make ASMs less effective.

Antonio Delgado-Escueta, MD, PhD, will be presented with the 2024 Founders Award during the 2024 Annual Meeting of the American Epilepsy Society (AES).

Eileen M. Murray, MM, CAE, will be presented with the 2024 Extraordinary Contributions to the Field of Epilepsy Award during the 2024 Annual Meeting of the American Epilepsy Society (AES).

Frances E. Jensen, MD, will be presented with the 2024 Distinguished Service Award during the 2024 Annual Meeting of the American Epilepsy Society (AES).

Gretchen L. Birbeck, MD, MPH, DTMH, will be presented the J. Kiffin Penry Award for Excellence in Epilepsy Care during the 2024 Annual Meeting of the American Epilepsy Society (AES).

Heather Mefford, MD, PhD, will be presented with the 2024 Basic Science Research Award during the 2024 Annual Meeting of the American Epilepsy Society (AES).

Karen Parko, MD, FAES, will be presented with the 57th Lombroso Lecturer Award during the 2024 Annual Meeting of the American Epilepsy Society (AES).

Phillip L. Pearl, MD, FAES, will present the Fritz E. Dreifuss Lecture during the Presidential Symposium at the 2024 Annual Meeting of the American Epilepsy Society (AES).

Sucheta M. Joshi MD, MS, FAES, will present the Rebecca Goldberg Kaufman AES Clinical Lecture in Ethical Neuropsychiatry during the Best Practices in Clinical Epilepsy Symposium at the 2024 Annual Meeting of the American Epilepsy Society (AES).

William Davis Gaillard, MD, FAES will be presented with the 2024 Clinical Science Research Award during the 2024 Annual Meeting.

AES establishes the Eileen Murray First-Generation Travel Award, supporting first-generation health professions students engaged in epilepsy research.

AES has announced the selection of Wendy-Jo Toyama, MBA, FASAE, CAE, as incoming chief executive officer, effective Nov. 25, 2024.

Undergraduates from Underrepresented Groups Pair with Mentors for Introduction to Epilepsy Science

A new guideline has been issued to help neurologists determine the best antiseizure medications for people with epilepsy who may become pregnant.

Eileen Murray, chief executive officer of AES, has announced that she plans to step down at the end of 2024, after 11 years of leadership.

AES has again earned the highest achievable rating from Charity Navigator, America’s largest and most-utilized independent charity evaluator.

AES 2023 – the world’s largest gathering of epilepsy professionals – has returned to pre-pandemic attendance levels with more than 5,950 attendees.

Jack M. Parent, M.D., has been elected second vice president of the American Epilepsy Society (AES), which is dedicated to advancing research and education for preventing, treating and curing epilepsy. Dr. Parent’s term will begin at the end of the Society’s 2023 Annual Meeting in Orlando, Fla., Dec. 1-5, 2023.

Renée Shellhaas, MD, MS, FAES, has been elected to the American Epilepsy Society (AES) board of directors beginning at the conclusion of the Society's 2023 Annual Meeting in Orlando, Fla., Dec. 1-5, 2023.

Black and Hispanic children and those on Medicaid are less likely to have surgery to treat drug-resistant epilepsy than white children and those with private insurance, even though the treatment is often more effective than medication alone, suggests a study of more than 18,000 children presented at the American Epilepsy Society Annual Meeting.

Brenda E. Porter, MD, PhD, FAES, was awarded the J. Kiffin Penry Award for Excellence in Epilepsy Care during the 2023 Annual Meeting of the American Epilepsy Society (AES).

Dave Clarke, MBBS, ABPN, ABCN, FAES, was presented the J. Kiffin Penry Award for Excellence in Epilepsy Care during the 2023 Annual Meeting of the American Epilepsy Society (AES).

Karen L. Secore, MS, APRN, CNRN, presented the Rebecca Goldberg Kaufman AES Clinical Lecture in Ethical Neuropsychiatry during the Best Practices in Clinical Epilepsy Symposium at the 2023 Annual Meeting of the American Epilepsy Society (AES).

Barbara C. Jobst, MD, Dr. med, FAAN, FAES has been elected to the American Epilepsy Society (AES) board of directors beginning at the conclusion of the Society's 2023 Annual Meeting in Orlando, Fla., Dec. 1-5, 2023.

Dimitri M. Kullmann, D.Phil., FRS, FMedSci, MAE, was presented with the 2023 Basic Science Research Award during the 2023 Annual Meeting of the American Epilepsy Society (AES).

People with epilepsy experience earlier decline in memory function – especially if they have cardiovascular risk factors like high blood pressure or diabetes — than those without the condition, according to results of a large study presented at the American Epilepsy Society Annual Meeting.

Elson L. So, MD was presented with the 2023 Distinguished Service Award during the 2023 Annual Meeting of the American Epilepsy Society (AES).

Mary Anne Meskis was presented with the 2023 Extraordinary Contributions to the Field of Epilepsy Award during the 2023 Annual Meeting of the American Epilepsy Society (AES).

More than 40% of adults with epilepsy have a genetic link to their condition, according to a study presented at the American Epilepsy Society Annual Meeting.

William H. Theodore, M.D., begins his term as president of the American Epilepsy Society (AES) at the conclusion of the Society’s 2023 Annual Meeting, held in Orlando, Fla., Dec. 1-5, 2023.

Early Research Pinpoints Area of the Brain Where Epileptic Activity May Occur in Some Alzheimer’s Disease Patients, Finding Could Lead to Targeted Treatments.

Bruce Hermann, PhD, FAES, was presented with the 2023 Founders Award during the 2023 Annual Meeting of the American Epilepsy Society (AES).

Elinor Ben-Menachem, MD, PhD, will begin a term as a member-at-large of the Nominating Committee of the American Epilepsy Society (AES) at the conclusion of the Society’s 2023 Annual Meeting in Orlando, Fla., Dec. 1-5, 2023.

Howard P. Goodkin, MD, PhD, has been elected first vice president of the American Epilepsy Society (AES), which is dedicated to advancing research and education for preventing, treating, and curing epilepsy.

Matthias J. Koepp, MD, PhD, was presented with the 2023 Clinical Science Research Award during the 2023 Annual Meeting of the American Epilepsy Society (AES).

Kelly G. Knupp, MD, MSCS, FAES, presented the Fritz E. Dreifuss lecture during the Presidential Symposium at the 2023 Annual Meeting of the American Epilepsy Society (AES).

American Epilepsy Society Awarded Grant to Improve Diagnostic Excellence by The Council of Medical Specialty Societies

The Sergievsky Award for Epilepsy Health Equity & Diversity is a grant for clinicians & scientists who are members of underrepresented minority groups